Hip involvement in hereditary hemochromatosis: a clinical-pathologic study.
Joint involvement occurs in about half the patients with hereditary hemochromatosis and may constitute the presenting manifestation. Joint damage is now the main cause of quality-of-life alterations in patients with hereditary hemochromatosis. The most common sites of involvement are the metacarpophalangeal joints and the hip. We report a case that illustrates the clinical, imaging-study, and pathological characteristics of hip disease in hereditary hemochromatosis.
Duval
Hélène
H
Département d'Anatomie et de Cytologie Pathologiques, CHU Pontchaillou, 2 Rue Henri Le Guilloux, 35033 Rennes, France. helene.duval@chu-rennes.fr
Lancien
Gérard
G
Marin
Franck
F
Ropars
Mickaël
M
Guggenbuhl
Pascal
P
Chales
Gérard
G
D000368:Aged; D019644:Arthroplasty, Replacement, Hip; D002358:Cartilage, Articular / Q000378:metabolism / Q000473:pathology; D005293:Ferritins / Q000097:blood; D006432:Hemochromatosis / Q000150:complications* / Q000175:diagnosis / Q000235:genetics*; D006621:Hip Joint / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D008297:Male; D015207:Osteoarthritis, Hip / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D014168:Transferrin / Q000378:metabolism
D014168:Transferrin; D005293:Ferritins